Access to hepatitis C treatment for patients in drug substitution programmes: the fight is far from over.
Sign Up to like & getrecommendations! Published in 2017 at "Swiss medical weekly"
DOI: 10.4414/smw.2017.14570
Abstract: More emphasis should be put on the advantages of providing HCV care for people who inject drugs in centralised rather than decentralised settings, possibly by expanding harm reduction programmes and integrating HCV services. read more here.
Keywords: hepatitis treatment; drug substitution; treatment patients; substitution programmes ... See more keywords
Facilitate access to hepatitis C treatment in opiate dependant patients: an strategy between different assistance levels
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Integrated Care"
DOI: 10.5334/ijic.s3368
Abstract: Introduction: The worldwide prevalence hepatitis C virus (HCV) is 2-3%. One of the most frequent route of infection is the use of injectable drugs, being the injecting drugs users (IVDU) and ex-IVDU a risk group,… read more here.
Keywords: treatment; facilitate access; hepatitis; access hepatitis ... See more keywords